Gene: TMEM132A
Official Full Name: transmembrane protein 132Aprovided by HGNC
Gene Summary: This gene encodes a protein that is highly similar to the rat Grp78-binding protein (GBP). Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02288 | TMEM132A Knockout cell line (HeLa) | Human | TMEM132A | 1:3~1:6 | Negative | Online Inquiry |
KO02289 | TMEM132A Knockout cell line (HCT 116) | Human | TMEM132A | 1:2~1:4 | Negative | Online Inquiry |
KO02290 | TMEM132A Knockout cell line (HEK293) | Human | TMEM132A | 1:3~1:6 | Negative | Online Inquiry |
KO02291 | TMEM132A Knockout cell line (A549) | Human | TMEM132A | 1:3~1:4 | Negative | Online Inquiry |
TMEM132A Gene Knockout Cell Lines are specifically engineered cellular models that have had the TMEM132A gene inactivated through precise genetic editing techniques such as CRISPR-Cas9. The TMEM132A gene encodes a protein believed to play a significant role in various cellular processes, including cell signaling, immune response modulation, and neuronal differentiation. By utilizing these knockout cell lines, researchers can investigate the biological functions of TMEM132A, allowing them to better understand its contribution to physiological and pathological conditions, particularly in neurodevelopmental and psychiatric disorders.
The primary mechanism underpinning the functionality of TMEM132A knockout cell lines lies in their ability to eliminate the gene’s expression, thus allowing for the characterization of downstream effects and phenotypic changes. Researchers can observe cellular behaviors such as altered proliferation, migration, and differentiation, which are critical for understanding disease mechanisms and therapeutic interventions.
The scientific importance of these cell lines is underscored by their utility in both basic research and clinical applications. They serve as valuable tools for drug discovery, helping to identify potential therapeutic targets and assess the efficacy of novel compounds. Additionally, they can be used to study the gene's involvement in disease models, particularly in exploring the genetic underpinnings of neuropsychiatric diseases where TMEM132A has been implicated.
Compared to traditional cell lines, TMEM132A Gene Knockout Cell Lines offer unique advantages such as specificity and enhanced reliability in studying gene function without the confounding effects of gene expression. This targeted approach reduces variability and improves the interpretability of experimental results, making these cell lines a superior choice for researchers focused on gene function analysis and therapeutic exploration.
For researchers and clinicians seeking to unlock the complexities of gene function and disease mechanisms, TMEM132A Gene Knockout Cell Lines represent an invaluable resource. With our extensive expertise in developing high-quality, genetically modified cellular models, our company is committed to advancing research and therapeutic discovery within the bio-sciences arena.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.